These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 29738265)
21. Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. Gijsbers L; Ding EL; Malik VS; de Goede J; Geleijnse JM; Soedamah-Muthu SS Am J Clin Nutr; 2016 Apr; 103(4):1111-24. PubMed ID: 26912494 [TBL] [Abstract][Full Text] [Related]
22. Dairy foods and cardiometabolic diseases: an update and a reassessment of the impact of SFA. Givens DI Proc Nutr Soc; 2023 Sep; 82(3):329-345. PubMed ID: 36740241 [TBL] [Abstract][Full Text] [Related]
23. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study. Marklund M; Zheng M; Veerman JL; Wu JHY PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090 [TBL] [Abstract][Full Text] [Related]
24. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Chen M; Sun Q; Giovannucci E; Mozaffarian D; Manson JE; Willett WC; Hu FB BMC Med; 2014 Nov; 12():215. PubMed ID: 25420418 [TBL] [Abstract][Full Text] [Related]
25. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis. Palmer AJ; Tucker DM Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888 [TBL] [Abstract][Full Text] [Related]
26. Dairy consumption and CVD: a systematic review and meta-analysis. Alexander DD; Bylsma LC; Vargas AJ; Cohen SS; Doucette A; Mohamed M; Irvin SR; Miller PE; Watson H; Fryzek JP Br J Nutr; 2016 Feb; 115(4):737-50. PubMed ID: 26786887 [TBL] [Abstract][Full Text] [Related]
27. A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease. Lamotte M; Annemans L; Evers T; Kubin M Pharmacoeconomics; 2006; 24(2):155-69. PubMed ID: 16460136 [TBL] [Abstract][Full Text] [Related]
28. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Tong X; Dong JY; Wu ZW; Li W; Qin LQ Eur J Clin Nutr; 2011 Sep; 65(9):1027-31. PubMed ID: 21559046 [TBL] [Abstract][Full Text] [Related]
29. Association between dairy intake and the risk of contracting type 2 diabetes and cardiovascular diseases: a systematic review and meta-analysis with subgroup analysis of men versus women. Mishali M; Prizant-Passal S; Avrech T; Shoenfeld Y Nutr Rev; 2019 Jun; 77(6):417-429. PubMed ID: 31222370 [TBL] [Abstract][Full Text] [Related]
30. Economic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trials. Kamstra R; Durkin M; Cai J; Bookhart B; Lafeuille MH; Pilon D; Tiggelaar S; Manceur AM; Lefebvre P J Med Econ; 2019 Mar; 22(3):280-287. PubMed ID: 30575426 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular Healthcare Cost Savings Associated with Increased Whole Grains Consumption among Adults in the United States. Murphy MM; Schmier JK Nutrients; 2020 Aug; 12(8):. PubMed ID: 32756452 [TBL] [Abstract][Full Text] [Related]
32. Impact of Treating Oral Disease on Preventing Vascular Diseases: A Model-Based Cost-effectiveness Analysis of Periodontal Treatment Among Patients With Type 2 Diabetes. Choi SE; Sima C; Pandya A Diabetes Care; 2020 Mar; 43(3):563-571. PubMed ID: 31882408 [TBL] [Abstract][Full Text] [Related]
33. Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective. Cedillo S; Sicras-Mainar A; Jiménez-Ruiz CA; Fernández de Bobadilla J; Rejas-Gutiérrez J Eur Addict Res; 2017; 23(1):7-18. PubMed ID: 27794567 [TBL] [Abstract][Full Text] [Related]
34. Dairy Products, Dairy Fatty Acids, and the Prevention of Cardiometabolic Disease: a Review of Recent Evidence. Yu E; Hu FB Curr Atheroscler Rep; 2018 Mar; 20(5):24. PubMed ID: 29564646 [TBL] [Abstract][Full Text] [Related]
35. Dairy intake and type 2 diabetes risk factors: A narrative review. Mitri J; Mohd Yusof BN; Maryniuk M; Schrager C; Hamdy O; Salsberg V Diabetes Metab Syndr; 2019; 13(5):2879-2887. PubMed ID: 31425952 [TBL] [Abstract][Full Text] [Related]
36. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis. Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315 [TBL] [Abstract][Full Text] [Related]
37. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. Elwood PC; Givens DI; Beswick AD; Fehily AM; Pickering JE; Gallacher J J Am Coll Nutr; 2008 Dec; 27(6):723S-34S. PubMed ID: 19155432 [TBL] [Abstract][Full Text] [Related]
38. Consumption of Dairy Foods and Cardiovascular Disease: A Systematic Review. Giosuè A; Calabrese I; Vitale M; Riccardi G; Vaccaro O Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215479 [TBL] [Abstract][Full Text] [Related]
39. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis. Javanbakht M; Mashayekhi A; Baradaran HR; Haghdoost A; Afshin A PLoS One; 2015; 10(7):e0132505. PubMed ID: 26200913 [TBL] [Abstract][Full Text] [Related]
40. Evidence of Dietary Improvement and Preventable Costs of Cardiovascular Disease. Zhang D; Cogswell ME; Wang G; Bowman BA Am J Cardiol; 2017 Nov; 120(9):1681-1688. PubMed ID: 28847593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]